Loading...
Biotech Regulation And Cash Burn Will Constrain Future Prospects
n/a
n/a
AnalystLowTarget's Fair Value
n/a
1Y
344.9%7D
8.6%1Y
344.9%7D
8.6%You can edit this narrative until Aug 12 10:36 PM. Then, changes will post as Updates.
You can edit this narrative until Aug 12 10:36 PM. Then, changes will post as Updates.